Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK – Get Free Report) Director Eric Andersen bought 101,050 shares of the company’s stock in a transaction that occurred on Thursday, December 7th. The stock was bought at an average cost of $12.85 per share, for a total transaction of $1,298,492.50. Following the completion of the transaction, the director now directly […]
Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK – Get Rating) Director Noah G. Levy bought 20,938 shares of the company’s stock in a transaction dated Tuesday, June 14th. The stock was purchased at an average cost of $5.17 per share, for a total transaction of $108,249.46. Following the completion of the acquisition, the director now owns 1,010,515 shares […]